EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Microglial ApoD ‐induced NLRC4 inflammasome activation promotes Alzheimer's disease progression

Yaliang Yu, Jianzhou Lv iD, Dan Ma, Ya Han, Yaheng Zhang, Shanlong Wang, Zhitao Wang

Animal Models and Experimental Medicine · 2025

DOI: 10.1002/ame2.12361 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Animal Models and Experimental Medicine, 2025. Verfasst von Yaliang Yu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Second Affiliated Hospital of Henan University of Science and Technology, Luoyang, P. R. China. Hauptthemen laut MEDLINE: Alzheimer Disease, Microglia, Inflammasomes, Calcium-Binding Proteins. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Alzheimer's disease (AD) is a progressive neurodegenerative disease with no effective therapies. It is well known that chronic neuroinflammation plays a critical role in the onset and progression of AD. Well‐balanced neuronal‐microglial interactions are essential for brain functions. However, determining the role of microglia—the primary immune cells in the brain—in neuroinflammation in AD and the associated molecular basis has been challenging.

Methods

Inflammatory factors in the sera of AD patients were detected and their association with microglia activation was analyzed. The mechanism for microglial inflammation was investigated. IL6 and TNF‐α were found to be significantly increased in the AD stage.

Results

Our analysis revealed that microglia were extensively activated in AD cerebra, releasing sufficient amounts of cytokines to impair the neural stem cells (NSCs) function. Moreover, the ApoD‐induced NLRC4 inflammasome was activated in microglia, which gave rise to the proinflammatory phenotype. Targeting the microglial ApoD promoted NSC self‐renewal and inhibited neuron apoptosis. These findings demonstrate the critical role of ApoD in microglial inflammasome activation, and for the first time reveal that microglia‐induced inflammation suppresses neuronal proliferation.

Conclusion

Our studies establish the cellular basis for microglia activation in AD progression and shed light on cellular interactions important for AD treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseMicrogliaInflammasomesCalcium-Binding ProteinsCARD Signaling Adaptor ProteinsApoptosis Regulatory ProteinsAnimalsHumansDisease ProgressionMaleNeural Stem CellsFemaleAgedMice

Stichwörter der Autor:innen

Alzheimer's diseaseApoDNLRC4 inflammasomemicroglia

Substanzen

InflammasomesCalcium-Binding ProteinsCARD Signaling Adaptor ProteinsNLRC4 protein, humanApoptosis Regulatory ProteinsIpaf protein, mouse

Autor:innen und Institutionen

  • Department of Neurology, The Second Affiliated Hospital of Henan University of Science and Technology, Luoyang, P. R. China.
  • Clinical Lab, The Second Affiliated Hospital of Henan University of Science and Technology, Luoyang, P. R. China.

ORCID-Profile: Jianzhou Lv

Zitieren

APA

Yu, Y., Lv, J., Ma, D., Han, Y., Zhang, Y., Wang, S., & Wang, Z. (2025). Microglial ApoD ‐induced NLRC4 inflammasome activation promotes Alzheimer's disease progression. Animal Models and Experimental Medicine. https://doi.org/10.1002/ame2.12361

Vancouver

Yu Y, Lv J, Ma D, Han Y, Zhang Y, Wang S, et al. Microglial ApoD ‐induced NLRC4 inflammasome activation promotes Alzheimer's disease progression. Animal Models and Experimental Medicine. 2025. doi:10.1002/ame2.12361

BibTeX
@article{Yu2025,
  author = {Yu, Yaliang and Lv, Jianzhou and Ma, Dan and Han, Ya and Zhang, Yaheng and Wang, Shanlong and Wang, Zhitao},
  title = {Microglial ApoD ‐induced NLRC4 inflammasome activation promotes Alzheimer's disease progression},
  journal = {Animal Models and Experimental Medicine},
  year = {2025},
  doi = {10.1002/ame2.12361}
}
Kostenlos starten →